These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2706094)

  • 1. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.
    Cushman DW; Wang FL; Fung WC; Harvey CM; DeForrest JM
    Am J Hypertens; 1989 Apr; 2(4):294-306. PubMed ID: 2706094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
    Sun Y; Mendelsohn FA
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ; Akarawut W; Smith DE
    Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
    Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
    Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
    Moulder JE; Cohen EP; Fish BL
    Int J Radiat Biol; 2014 Sep; 90(9):762-8. PubMed ID: 24991882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
    Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G
    Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC; White CM
    Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer ACE inhibitors. A look at the future.
    Salvetti A
    Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
    Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors.
    Ranadive SA; Chen AX; Serajuddin AT
    Pharm Res; 1992 Nov; 9(11):1480-6. PubMed ID: 1475237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
    Bender N; Rangoonwala B; Rosenthal J; Vasmant D
    Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme.
    DeForrest JM; Waldron TL; Krapcho J; Turk C; Rubin B; Powell JR; Cushman DW; Petrillo EW
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):887-94. PubMed ID: 2484083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.